Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Pharmaceuticals Share News (HEMO)

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes
Get Live Data
794.00    -35.50 (-4.44%)
Bid:
735.00
Ask:
794.00
Spread: 59.00 (8.027%)
Market Cap: £53.99m
HEMO Live PriceLast checked at - London Stock Exchange

Intraday Hemogenyx Pharmaceuticals Share Chart

Hemogenyx Pharmaceuticals News

Hemogenyx raises GBP4 million in share placing for Hemo-CAR-T product
26 Jan 2023

Hemogenyx raises GBP4 million in share placing for Hemo-CAR-T product

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said it successfully raised GBP4.1 million in a placing of new shares, with the fresh cash...

IN BRIEF: Hemogenyx completes process run for HEMO-CAR-T manufacture
23 Jan 2023

IN BRIEF: Hemogenyx completes process run for HEMO-CAR-T manufacture

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for deadly blood diseases - Completes thi...

Hemogenyx shares up on single target protein virus treatment finding
9 Jan 2023

Hemogenyx shares up on single target protein virus treatment finding

(Alliance News) - Hemogenyx Pharmaceuticals PLC shares jumped early Monday, after the company announced the discovery of a single target protein for u...

IN BRIEF: Hemogenyx Pharma second process qualification run successful
4 Jan 2023

IN BRIEF: Hemogenyx Pharma second process qualification run successful

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Successfully completes its second process qualification run of the end-to-end pro...

SMALL-CAP WINNERS & LOSERS: HeiQ drops on expectation of lower sales
4 Jan 2023

SMALL-CAP WINNERS & LOSERS: HeiQ drops on expectation of lower sales

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

Hemogenyx makes final development run of HEMO-CAR-T cell manufacture
18 Nov 2022

Hemogenyx makes final development run of HEMO-CAR-T cell manufacture

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said it has completed the final development run for its manufacturing process of HEMO-CAR-T ...

EARNINGS UPDATES: Hemogenyx hopes on cancer drug; IDE loss widens
29 Sep 2022

EARNINGS UPDATES: Hemogenyx hopes on cancer drug; IDE loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Hemogenyx wins patent for bi-specific antibody method in China
15 Aug 2022

Hemogenyx wins patent for bi-specific antibody method in China

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has been awarded a patent for its bi-specific antibody in China.